<SEC-DOCUMENT>0001144204-16-111708.txt : 20160706
<SEC-HEADER>0001144204-16-111708.hdr.sgml : 20160706
<ACCEPTANCE-DATETIME>20160706163623
ACCESSION NUMBER:		0001144204-16-111708
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20160706
DATE AS OF CHANGE:		20160706
EFFECTIVENESS DATE:		20160706

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Synthetic Biologics, Inc.
		CENTRAL INDEX KEY:			0000894158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133808303
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12584
		FILM NUMBER:		161754171

	BUSINESS ADDRESS:	
		STREET 1:		617 DETROIT STREET, SUITE 100
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48104
		BUSINESS PHONE:		(734) 332-7800

	MAIL ADDRESS:	
		STREET 1:		155 GIBBS STREET
		STREET 2:		SUITE 412
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADEONA PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PIPEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20061214

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SHEFFIELD PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19970730
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>v443219_defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML>

     <HEAD>

          <TITLE></TITLE>

     </HEAD>

<BODY>

<DIV style="text-align: center; min-width: 708">


<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">UNITED STATES<BR> SECURITIES AND EXCHANGE COMMISSION<BR> Washington, D.C. 20549 </H1>


<DIV ALIGN="CENTER"><BR><IMG SRC="line.gif" ALIGN="MIDDLE" STYLE="width: 180px; height: 1pt; text-align: center"><BR>&nbsp;</DIV>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">SCHEDULE 14A<BR> (RULE 14a-101)<BR> INFORMATION REQUIRED IN PROXY STATEMENT<BR> &nbsp;<BR>SCHEDULE 14A INFORMATION </H1>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Proxy Statement Pursuant to Section 14(a) of the<BR> Securities Exchange Act of 1934 </H1>


<DIV ALIGN="CENTER"><BR><IMG SRC="line.gif" ALIGN="MIDDLE" STYLE="width: 180px; height: 1pt; text-align: center"><BR>&nbsp;</DIV>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 240px; text-align: left">Filed by the Registrant</TD>

          <TD STYLE="text-align: left"><FONT STYLE="font-family: wingdings">x</font> </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 240px; text-align: left">Filed by a Party other than the Registrant</TD>

          <TD STYLE="text-align: left"><FONT STYLE="font-family: wingdings">o</font> </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Check the appropriate box: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: left">Preliminary Proxy Statement </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><B><FONT STYLE="font-family: wingdings">o</font></B></TD>

          <TD STYLE="text-align: left"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B> </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: left">Definitive Proxy Statement </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">x</font></TD>

          <TD STYLE="text-align: left">Definitive Additional Materials </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: left">Soliciting Material under &sect;240.14a-12 </TD>

</TR>

</TABLE>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 18pt; line-height: 20pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">SYNTHETIC BIOLOGICS, INC. </H1>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 8pt; line-height: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>(Name of Registrant as Specified in Its Charter)</I> </P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 264px; height: 1pt"></P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 8pt; line-height: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</I> </P>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Payment of Filing Fee (Check the appropriate box): </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">x</font></TD>

          <TD STYLE="text-align: left">No fee required. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: left">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 41px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: left">Title of each class of securities to which transaction applies: </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 41px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: left">Aggregate number of securities to which transaction applies: </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 41px"></TD>

          <TD STYLE="width: 20px; text-align: left">(3)</TD>

          <TD STYLE="text-align: left">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 41px"></TD>

          <TD STYLE="width: 20px; text-align: left">(4)</TD>

          <TD STYLE="text-align: left">Proposed maximum aggregate value of transaction: </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 41px"></TD>

          <TD STYLE="width: 20px; text-align: left">(5)</TD>

          <TD STYLE="text-align: left">Total fee paid: </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: left">Fee paid previously with preliminary materials. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: left">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 41px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: left">Amount Previously Paid: </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 41px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: left">Form, Schedule or Registration Statement No.: </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 41px"></TD>

          <TD STYLE="width: 20px; text-align: left">(3)</TD>

          <TD STYLE="text-align: left">Filing Party: </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 41px"></TD>

          <TD STYLE="width: 20px; text-align: left">(4)</TD>

          <TD STYLE="text-align: left">Date Filed: </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="logo_syntheticbio.jpg" WIDTH="206" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]"></P>

<P STYLE="text-indent:0pt; text-align: right; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">July 6, 2016</P>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Dear Fellow Shareholders,</P>

<P STYLE="text-indent:20px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The last year was a transformative one for our company. When we set out on our journey to develop pathogen-specific, microbiome-focused product candidates three years ago, our long-term goal was to develop and commercialize clinically relevant and differentiated products in order to address large markets with clear unmet medical needs. Our focus remains to build a strong portfolio of microbiome-focused products while continuing to create value for our shareholders and we feel a great sense of purpose and pride in continuing to develop our two lead, potential multi-billion dollar, microbiome-focused programs. The achievement of
important milestones demonstrates our sustained clinical progress, our ability to operate efficiently and that we are well positioned to initiate Phase 3 clinical trials for our lead microbiome-focused drug candidates. </P>

<P STYLE="text-indent:20px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In the past year, we announced results from two Phase 2 clinical trials for SYN-010, our modified-release formulation of lovastatin lactone intended to reduce methane production by certain microorganisms in the gut while minimizing disruption to the microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C). Data from both trials demonstrate clinically meaningful improvements at both primary and secondary endpoints, including a reduction of breath methane and increases in quality of life scores for abdominal pain and bloating in IBS-C patients. Positive clinical results from two Phase 2a
trials for SYN-004, our oral prophylactic therapy designed to degrade certain IV beta-lactam antibiotics within the gastrointestinal (GI) tract to preserve the natural balance of the gut microbiome for the prevention of Clostridium difficile infection (CDI), antibiotic-associated diarrhea (AAD) and emergence of antibiotic-resistant organisms, demonstrate a correlation of SYN-004 with the degradation of ceftriaxone in study participants.</P>

<P STYLE="text-indent:20px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Looking ahead, we remain on schedule to hold an end of Phase 2 meeting with the FDA this summer to discuss clinical trial development for the initiation of a Phase 3 clinical trial for SYN-010. Our Phase 2b proof-of-concept clinical trial to evaluate the ability of SYN-004 to prevent CDI and AAD is ongoing and an interim analysis of blinded data performed by an independent data monitoring committee is expected later this year. In addition, our pipeline of discovery and preclinical and therapeutic programs for pertussis (whooping cough), phenylketonuria (PKU) and oral alkaline phosphatase (IAP) remains robust. </P>

<P STYLE="text-indent:20px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">I would like to thank our dedicated employees for their purposeful commitment, our clinical advisors for their valuable expertise in our areas of pursuit, our loyal shareholders for their unwavering support of our innovative programs and goals, and our collaborators for their contribution to our efforts. With sustained clinical momentum and support from positive results from multiple clinical trials, Synthetic Biologics continues to pivot from an early-stage clinical company focused on drug development, to a late-stage clinical company focused on Phase 3 initiation and commercial entry. We look forward to reporting our
progress to you during what promises to be a very exciting and eventful year for Synthetic Biologics.</P>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Sincerely,</P>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="sig_jeffrey-riley.jpg" WIDTH="128" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]"></P>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Jeffrey Riley<BR>Chief Executive Officer</P>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>This letter includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, on Synthetic Biologics&#146; current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as &#147;may,&#148; &#147;should,&#148; &#147;potential,&#148; &#147;continue,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;indicates,&#148; and similar expressions. These statements are based upon management&#146;s current beliefs,
expectations and assumptions and </I></P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding our timeline for our SYN-004 and SYN-010 clinical trials and reporting of data, the size of the market, benefits to be derived from use of SYN-004 and SYN-010 and our execution of our growth strategy. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Synthetic
Biologics&#146; forward-looking statements include, among others, our product candidates demonstrating safety and effectiveness, as well as results that are consistent with prior results, our ability to initiate clinical trials and if initiated, our ability to complete them on time and achieve the desired results and benefits, our clinical trials continuing enrollment as expected, our ability to obtain regulatory approval for our commercialization of product candidates or to comply with ongoing regulatory requirements, regulatory limitations relating to our ability to promote or commercialize our product candidates for the specific indications, acceptance of our product candidates in the marketplace and the successful development, marketing or sale of our products, developments by competitors that render our products obsolete or non-competitive, our ability to maintain our license agreements, the continued maintenance and growth of our patent estate, our ability to become or remain
profitable, our ability to establish and maintain collaborations, our ability to obtain or maintain the capital or grants necessary to fund our research and development activities, a loss of any of our key scientists or management personnel, and other factors described in Synthetic Biologics&#146; annual report on Form 10-K for the year ended December 31, 2015, subsequent quarterly reports on Forms 10-Q and any other filings we make with the SEC. The information in this letter is provided only as of the date presented, and Synthetic Biologics undertakes no obligation to update any forward-looking statements contained in this letter on account of new information, future events, or otherwise, except as required by law.</I></P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">



</DIV>

</B></B></B></B></B></B></B></B></B></B></B></B></B></B></B></B></B></B>

</I></I></I></I></I></I></I></I></I></I></I></I></I></I></I></I></I></I>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>line.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 line.gif
K1TE&.#EA 0 ! (       /___R'Y!       +      !  $   ("1 $ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo_syntheticbio.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo_syntheticbio.jpg
M_]C_X  02D9)1@ ! 0$ KP"O  #_X@H@24-#7U!23T9)3$4  0$   H0
M  (0  !M;G1R4D="(%A96B                !A8W-P05!03
M                        ]M4  0    #3+
M                                              ID97-C    _
M 'QC<')T   !>    "AW='!T   !H    !1B:W!T   !M    !1R6%E:   !
MR    !1G6%E:   !W    !1B6%E:   !\    !1R5%)#   "!   " QG5%)#
M   "!   " QB5%)#   "!   " QD97-C         ")!<G1I9F5X(%-O9G1W
M87)E('-21T(@24-#(%!R;V9I;&4              ")!<G1I9F5X(%-O9G1W
M87)E('-21T(@24-#(%!R;V9I;&4
M            =&5X=     !#;W!Y<FEG:'0@07)T:69E>"!3;V9T=V%R92 R
M,#$Q %A96B        #S40 !     1;,6%E:(                     !8
M65H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M 0$! 0$! ?_  !$( '(!>0,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M6+P[CAL;A*DJ?UG!4J>(PM?$Z\&\7\,\?9=4S/A?,8XZCAZJH8S#U:-7"8_
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M6%SIF@IJMS!;V\W]EZ?>7^J7-I;,MLCB&6_N2KL^UPA5%]C@'@R&.EB\;GF
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MU?4M=UB]\BUMOMFJZO>3:AJ%U]FLXK>TM_M%W<33>1:V\%M%O\N"&*)51?\
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MTKP7;+'&)-9FM/$^DZ9_;>KR>:4T'3H[:[TJ.YBGU#7G>ULK?0_$'S3\._\
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M ?#1=:\7SPPV:7C>._BT]CKL>EW\T*&\N(-)\!Z3X+U/3$O9MMLWBG4_LEI
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M?PN^'7P<_:2_8(_9V^,/Q:^$7PU^)GB[7?V)OA9XDLO$GQ(^'_A'QCXFT_\
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M%NG:OK&J6>K0:>]^-/\ #^J+=Q:'H-G:W44T\\^F;T^WV?X1_P#!6+_@J/\
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MHT+6+3Q#HFCZ_I[%K#7-*T_6+)FQN:TU.TAO;9CM++DPSH3M)&>A(YK\Y?\
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M-<1A/$?'8/"U\RQ-&C3K8ZMAL)&.%P]7%5*TZ.&C&A3E"DE!?E%_P4@_:O\
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M2KF6]TAKNRL]:\.:A::WH]S-*-)\1Z5K=E?6L$WDW<.I16>F1V'Z'45[6?\
M#V3<49;4RC/<#3Q^ JU:-?V4JE>A4I8C#5%5PV*PV)PM;#XK"8K#U%ST<3AJ
M]&M3;?+.TI1?RG!?&_%/A[GU#B;@_-ZV39S0H8O"?6*='"8NAB<#CZ+P^.R_
M'X#,,-C<NS++\;0?LL5@<?@\3A:\5'GIJ4(37YW?LD?\$^M#_9N\>>)/C'XU
M^*/B?XY_&?Q18W&G77CCQ3:369LK>_EBEU.>"+4-:\3:O?:SJ*6]K9WFN:GK
MUS/)90O;VUM91W=W'+^B-%%&0<.Y-POET,IR+!0P.!A6KXETU5Q&(JUL5BI^
MUQ.*Q6*Q=?$XO%XK$5+2K8C$XBM5J-*\DDD'&G''%/B%GM7B3C#-JF<9O4PN
M$P,:TL/@L%A\+E^7T?J^ R[+\NRW"8#+<MR_!46Z>%P6 P6&PU&,I.--RG*0
M4445[1\H<EX\\!^#_B?X/\0> ?'V@6'BCPAXHL'TW7-$U))#;W=NSQS121S0
M20W=C?V-W#;ZAI6JZ?<6NJ:/JEK9ZKI5Y9ZC9VMU#_*Y^V;^P'\3_P!ES5-?
M\7:)::AXV^ D>H:<ND>/XWL9M4\/IKMQ<V^GZ%X]TJS>&[L+^QNX8=*D\66N
MEP>#M;N=1\/^1<Z-KWB!/!^F?UH5GZMI.E:]I6IZ%KNF:?K6B:UI]YI.L:/J
MUG;:CI6K:5J-M)9ZAIFIZ?>1S6E_I]_:336MY9W4,MM=6TLD$\;Q.RG\H\4_
M"+AWQ2RVG#'IY?GV I5HY/GV'IPE7P[G&<HX/'0Y4\?E,\0X5:N%E.%:A-SQ
M&7U\-7E5AB_WOP)^D#Q;X&YU4JY:HYSPIFN(PTN(N%,96J0PV+C3G3A/,<JK
M<THY5G]+"*I0H8^-*IAL535+"9MA,9A84:N _@V^UCU/Y'_&C[6/4_D?\:_H
M_P#VK?\ @D1X&^)%Y+XP_9NU#P_\(_$TWVN;5O VL1:S)\./$.HZCKL5[)J6
MG7ED^K:A\._L.GWFK1)HN@>'M8\+7,5EX=T?1M \'P0:GJE]^&'Q?_9)_:7^
M UM/J/Q3^#7C#P[H=II]AJ=_XILK6U\5>#-,MM4U5]$T^+5O&O@^\U_PGI.H
M76JB*SCTG4M9M=5\R]TQFLEBU73)+O\ SXXU\%^..!<1B%F>38G&Y91YI4\_
MRC#XC'Y15H1N_:U:U&E4K9>U%-U:.9T,)*DXU&Z]2E%8B7^PGA9](/PD\6\'
M@Y9!Q-@,LS[$J%.MPAQ'C,#E'$F'Q4K1^KX?#8K$T,-G,93:5#$9%B\RAB%4
MHI82CB*CP</#_M8]3^1_QH^UCU/Y'_&N>^TK_D'_ !H^TK_D'_&OS3ZFNWX?
M\$_=OJ7]W\CH?M8]3^1_QH^UCU/Y'_&N>^TK_D'_ !KH/"WAOQ1XYUZP\+>"
M?#/B#QCXGU3[5_9GASPMHFI>(=>U'[%9W&HWOV#2-)M[O4+O[)I]I=W]U]GM
MY/L]G:W%U+L@@E=;IY=4K5*=&C2J5JU6<:=*C1I5*U6K4G)1A3I4J4*M6K4G
M)J,*=.E4J3DU&$)2:B\J]&AA:%;$XJK1PN&P]*I7Q&)Q->AAL-AZ%*+G5K8C
M$8BKA\/0HTH1E.K6KUZ-&G"+G4JTX)S2_:QZG\C_ (U^P?\ P2R_8ZU;XF^.
M]*_:)^(>@ZA:_"_P#?IJOPYGEU"YT=_&/Q-\/ZS9RZ;J5E:PVYN]7\(>#+NS
MOI]3O([_ $O3[WQC::5H22^(K+3/'.AV>[^R1_P2)\5^+AX1^)'[2VH?\(CX
M2NO[,U__ (4[90ZE#X[US3I/[3D_L7QUJ?F:;_PKO[3Y.@WEYINDMKGBJ31]
M3U31+^;X=^+;'SK'^BG2=)TK0=*TS0M"TS3]%T31=/L])T?1])L[;3M*TG2M
M.MH[/3],TS3[..&TL-/L+2&&UL[.UABMK6VBC@@C2)%4?UUX&_1[S"IFF XR
MXZP%3+\!EU7#9ADN0XNG!8O,\7#DQ.$QN9X:3E/!Y?A*BP^)HX/$1I8W&8JG
MA95J&$PF&G#$_P"<?TJ?I:</83),V\-O"G-J&=9QFU''91Q/Q;EU6I++<BP$
MW5P6897D>.A&%+,\XQ]/ZW@L1F."GB,KRW 5L=##XO,<PQE.I@]"BBBO[L/\
MJPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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0K^RS_*T**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>sig_jeffrey-riley.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sig_jeffrey-riley.jpg
M_]C_X  02D9)1@ ! 0$ KP"O  #_X@H@24-#7U!23T9)3$4  0$   H0
M  (0  !M;G1R4D="(%A96B                !A8W-P05!03
M                        ]M4  0    #3+
M                                              ID97-C    _
M 'QC<')T   !>    "AW='!T   !H    !1B:W!T   !M    !1R6%E:   !
MR    !1G6%E:   !W    !1B6%E:   !\    !1R5%)#   "!   " QG5%)#
M   "!   " QB5%)#   "!   " QD97-C         ")!<G1I9F5X(%-O9G1W
M87)E('-21T(@24-#(%!R;V9I;&4              ")!<G1I9F5X(%-O9G1W
M87)E('-21T(@24-#(%!R;V9I;&4
M            =&5X=     !#;W!Y<FEG:'0@07)T:69E>"!3;V9T=V%R92 R
M,#$Q %A96B        #S40 !     1;,6%E:(                     !8
M65H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M 0$! 0$! ?_  !$( &0!) ,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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MDN[20^5<PQ2 H ;BUNFO5-'I%%%% @HHHH ^4?CW^W7^QG^RY.UC^T)^T_\
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M1^ZNG6&WG\.Z!'INCAVO9_"/B">WL4M?W&HH)4FM;OSOJGZIW3^9^)?[!?\
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MAM=;\66GA^'PK!X@O804?5/^$=MM0U2UTJ:Z0(]S:VEZ]F+DRR6D-I;O%:0
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M]LSP7IL:RR^//V>)(D\;ZS;6\4:7MY./A!<>/[&PC_=-<I;WGP)\-7"S/=2
M26#6J6H+D3^&47Y-\K^YZ?<S^L6BOYE?AY_P=+_L3#4!X4_:>^"?[47[)_CV
MWACN-2T?QK\/(_%6B6L4TGE1&"[T2]LO'4S%H[AG:\^&FF6^R$B"XN)B\,7Z
M:?"K_@LU_P $L?C,+;_A"_VYO@%9RWJVYM;3XB^*W^#6H3O=.\=O;1Z;\8;+
MP+?F]DD0QBP^S?;1(\*-;AKB 2 G"2WB_NNOO5T?IM17!>!_BK\+_B=:"_\
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M-1EN?@WJ&K/YH<RRR6FJ6D[S?-YH4LK%%!C5DX_"[:K:RZ>A^]?P4_X-[O\
M@DM\$I(KVR_96T;XEZU',LAUCXU^*O%_Q/CE2.6.:&WE\*:_K3^ ##&Z'<R>
M$$GNHI)+>]GNK<K$OZZ^!?AYX ^%WARS\'_#/P-X/^'?A+3\?8/"W@7PSHOA
M'PY8[88;<?8]$T"RT_3+;%O;V\ \FU3$,$,0^2)%4HH,&V]VWZML["BBB@04
&444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
